| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/TP.0B013E3181837626 |
| P698 | PubMed publication ID | 18791449 |
| P2093 | author name string | Mark D Stegall | |
| Patrick G Dean | |||
| Sanjeev Sethi | |||
| Naim Issa | |||
| James M Gloor | |||
| Fernando G Cosio | |||
| S Breanndan Moore | |||
| Steve DeGoey | |||
| P2860 | cites work | Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause | Q43580802 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | transplant glomerulopathy | Q16258703 |
| P304 | page(s) | 681-685 | |
| P577 | publication date | 2008-09-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels | |
| P478 | volume | 86 |
| Q42922850 | A clinical and pathological variant of acute transplant glomerulopathy |
| Q47578423 | A significant role for anti-human leukocyte antigen antibodies and antibody-mediated rejection in the biopsy-for-cause population. |
| Q38211716 | A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection |
| Q38215262 | Acute and chronic antibody-mediated rejection in pediatric kidney transplantation |
| Q92322383 | An in vitro model of antibody-mediated injury to glomerular endothelial cells: Upregulation of MHC class II and adhesion molecules |
| Q34753378 | B-cell complement dependent cytotoxic crossmatch positivity is an independent risk factor for long-term renal allograft survival |
| Q42943616 | C4d-Positive Renal Allograft Rejection Biopsies in Cyclosporine-Treated Patients: Single-Center Incidence and Outcome |
| Q35788603 | Clinical relevance of pretransplant HLA class II donor-specific antibodies in renal transplantation patients with negative T-cell cytotoxicity crossmatches |
| Q37367683 | Combination of peritubular c4d and transplant glomerulopathy predicts late renal allograft failure. |
| Q39118422 | Desensitization Protocol in Recipients of Deceased Kidney Donor With Donor-Specific Antibody-Low Titers |
| Q82343270 | Detection of donor-specific HLA antibodies before and after removal of a rejected kidney transplant |
| Q42111937 | Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation. |
| Q39801687 | Donor-specific antibodies present at the time of kidney transplantation in immunologically unmodified patients increase the risk of acute rejection. |
| Q36554486 | Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study |
| Q27027082 | Effector mechanisms of rejection |
| Q34457101 | Fibrosis with inflammation at one year predicts transplant functional decline. |
| Q64226624 | Glomerular C3 Deposition Is an Independent Risk Factor for Allograft Failure in Kidney Transplant Recipients With Transplant Glomerulopathy |
| Q36304550 | High Serum Level of β2-Microglobulin in Late Posttransplant Period Predicts Subsequent Decline in Kidney Allograft Function: A Preliminary Study |
| Q33352583 | Humoral immunity in chronic allograft rejection: puzzle pieces come together |
| Q37535280 | Identification and characterization of kidney transplants with good glomerular filtration rate at 1 year but subsequent progressive loss of renal function |
| Q47800223 | Immunoglobulin isotype switching of antibodies to vimentin is associated with development of transplant glomerulopathy following human renal transplantation |
| Q46245832 | Impact of the presence and duration of donor-specific antibodies on renal function |
| Q37375622 | Incidence and clinical significance of de novo donor specific antibodies after kidney transplantation |
| Q53060554 | Increased intragraft rejection-associated gene transcripts in patients with donor-specific antibodies and normal biopsies. |
| Q36007256 | Interpreting Anti-HLA Antibody Testing Data: A Practical Guide for Physicians |
| Q50993047 | Kidney Transplant With Low Levels of DSA or Low Positive B-Flow Crossmatch: An Underappreciated Option for Highly Sensitized Transplant Candidates. |
| Q45172148 | Late acute humoral rejection in low-risk renal transplant recipients induced with an interleukin-2 receptor antagonist and maintained with standard therapy: preliminary communication |
| Q33891669 | Neutralizing BAFF/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model. |
| Q37898509 | New therapeutic approaches to antibody-mediated rejection in renal transplantation |
| Q44215754 | Predicting renal graft failure by sCD30 levels and de novo HLA antibodies at 1year post-transplantation |
| Q51296997 | Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation. |
| Q36913888 | Red blood cell transfusion risks in patients with end-stage renal disease |
| Q38544617 | Relationship among C1q-fixing de novo donor specific antibodies, C4d deposition and renal outcome in transplant glomerulopathy. |
| Q52656964 | Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation. |
| Q26864255 | Role of complement and NK cells in antibody mediated rejection |
| Q82046014 | Significant association between chronic antibody-mediated rejection and donor-specific antibodies against HLA-DRB rather than DQB in renal transplantation |
| Q35669313 | Surveillance of alloantibodies after transplantation identifies the risk of chronic rejection |
| Q49521510 | The Role of the Endothelium during Antibody-Mediated Rejection: From Victim to Accomplice |
| Q48224009 | The clinical implications of the unique glomerular complement deposition pattern in transplant glomerulopathy |
| Q38630386 | The over-exaggerated chronic nephrotoxicity of calcineurin inhibitors |
| Q37813404 | The pathology of chronic allograft dysfunction |
| Q34269169 | The prevalence of immunologic injury in renal allograft recipients with de novo proteinuria |
| Q38048605 | The role of complement in antibody-mediated rejection in kidney transplantation |
| Q38151921 | The specificity of acute and chronic microvascular alterations in renal allografts |
| Q82064319 | The strength of donor-specific antibody is a more reliable predictor of antibody-mediated rejection than flow cytometry crossmatch analysis in desensitized kidney recipients |
| Q35777001 | Transfusion-related acute lung injury: incidence and risk factors. |
| Q50063069 | Transplant glomerulopathy |
| Q38205229 | Transplant glomerulopathy: the interaction of HLA antibodies and endothelium |
| Q37052024 | Tubuloreticular Inclusions in Renal Allografts Associate with Viral Infections and Donor-Specific Antibodies |
Search more.